Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells

In conclusion, combination of VX-11e and voreloxin can exert a synergistic anticancer effect in leukemia cells.
Source: Apoptosis - Category: Molecular Biology Source Type: research